BIOSYNERGY INC: 10-Q filed 2019-12-16
What BIOSYNERGY INC reported in its quarterly report filed 2019-12-16 (fiscal Q2 2019): 25 published measures, 66 facts as tagged in accession 0000715812-19-000026.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-12-16
- Fiscal period
- fiscal Q2 2019
- Accession
- 0000715812-19-000026 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All BIOSYNERGY INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 1,835,001 | USD | |
| At 2019-04-30 | 1,872,879 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 1,717,884 | USD | |
| At 2019-04-30 | 1,692,316 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 1,224,170 | USD | |
| At 2019-04-30 | 1,180,125 | USD | |
| At 2018-10-31 | 1,177,713 | USD | |
| At 2018-04-30 | 1,140,428 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 16,990 | USD | 92 |
| 2019-05-01 to 2019-10-31 | 25,568 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 25,997 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 36,376 | USD | 184 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-10-31 | 44,045 | USD | 184 |
| 2018-05-01 to 2018-10-31 | 40,826 | USD | 184 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 1,076,595 | USD | |
| At 2019-04-30 | 1,051,027 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 6,771 | USD | 92 |
| 2019-05-01 to 2019-10-31 | 10,191 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 10,368 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 14,507 | USD | 184 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 9,478 | USD | |
| At 2019-04-30 | 12,316 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 23,131 | USD | 92 |
| 2019-05-01 to 2019-10-31 | 34,499 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 35,753 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 49,699 | USD | 184 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 1,663,155 | USD | |
| At 2019-04-30 | 1,646,824 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 92,845 | USD | |
| At 2019-04-30 | 156,291 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 6,306 | USD | |
| At 2019-04-30 | 4,538 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 242,190 | USD | |
| At 2019-04-30 | 246,363 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 180,619 | USD | 92 |
| 2019-05-01 to 2019-10-31 | 378,859 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 184,791 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 384,760 | USD | 184 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 203,750 | USD | 92 |
| 2019-05-01 to 2019-10-31 | 413,358 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 220,544 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 434,459 | USD | 184 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 39,175 | USD | 92 |
| 2019-05-01 to 2019-10-31 | 79,097 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 38,911 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 75,832 | USD | 184 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 14,935,511 | shares | |
| At 2019-04-30 | 14,935,511 | shares |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 44,550 | USD | |
| At 2019-04-30 | 89,100 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 227,298 | USD | |
| At 2019-04-30 | 227,298 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 217,820 | USD | |
| At 2019-04-30 | 214,982 | USD |
Net deferred tax liabilities
Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-10-31 | 24,272 | USD | |
| At 2019-04-30 | 24,272 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-08-01 to 2019-10-31 | 97,678 | USD | 92 |
| 2019-05-01 to 2019-10-31 | 208,194 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 97,615 | USD | 92 |
| 2018-05-01 to 2018-10-31 | 214,955 | USD | 184 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-10-31 | 2,837 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 4,176 | USD | 92 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-10-31 | 6,822 | USD | 184 |
| 2018-08-01 to 2018-10-31 | 5,583 | USD | 92 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-05-01 to 2019-10-31 | -5,719 | USD | 184 |
| 2018-05-01 to 2018-10-31 | 2,309 | USD | 184 |
Inspect the source
- Entity
- BIOSYNERGY INC / CIK 0000715812
- Captured
- SEC response SHA-256
eb912604535d1396c8e2ed6025c6adab35af75fdfc7239083d444e5a31df6a03
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000715812.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))